Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and stands as the second leading cause of cancer-related mortality. Despite ...
The age of testing for colorectal cancer has been pushed from 50 to 45, and it is even earlier for at-risk patients because of the rise in the number of young adults being diagnosed with the disease.
Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation ... Objective response rate: the percentage of patients with a partial or ...